More details
Hide details
Department of Otorhinolaryngology, University and Hospital Center of Coimbra, Coimbra, Portugal
Publication date: 2015-06-30
Corresponding author
Raquel Ferreira   

Raquel Ferreira, Department of Otorhinolaryngology, Hospital and University of Coimbra, Maia, Portugal, e-mail: raquelf.santos@gmail.com
J Hear Sci 2015;5(2):36–41
Children with congenital cytomegalovirus (CMV) infection face a bigger risk of neurological deficits and developmental delays associated with sensorineural hearing loss (SNHL). Their rehabilitation with a cochlear implant (CI) may therefore be inferior to the paediatric population in general. This study describes post-implant outcomes in children with CMV-related deafness and compares them to children with genetic deafness caused by GJB2 mutation (connexin 26) rehabilitated at the Centro Hospitalar e Universitário de Coimbra, Portugal.

Material and Methods:
We conducted a revision of 11 children with profound hearing loss caused by congenital CMV infection rehabilitated with a CI in our institution. The children were divided into 3 groups according to age of implantation (<2 years, 2–3 years, >3 years) and their performance was compared to a group of children with genetic hearing loss caused by GJB2 mutation. To compare performance the following tests were applied: SIR, CAP, vocal characteristics evaluation grid (VCEG), MAIS, and MUSS.

We found no differences between the two groups in terms of hearing thresholds obtained with a CI. In spite of a wider spread of results in the CMV group, there were no significant statistical differences in the SIR and VCEG tests or in the MAIS and MUSS questionnaires. There was a significant difference in the CAP test (p=0.049) where the GJB2 group had superior results.

The present study has shown that the CMV group had poorer results for the CAP test and a wider spread of results in the other tests. However, the CMV group attained results comparable to children with profound hearing loss and no other deficit, and benefited from rehabilitation with a cochlear implant.

Ciorba A, Bovo R, Trevisi P, Bianchini C, Arboretti R, Martini A. Rehabilitation and outcome of severe profound deafness in a group of 16 infants affected by congenital cytomegalovirus infection. Eur Arch Otorhinolaryngol, 2009; 266: 1539–46.
Malik V, Bruce IA, Broomfield SJ, Henderson L, Green KM, Ramsden RT. Outcome of cochlear implantation in asymptomatic congenital cytomegalovirus deafened children. Laryngoscope, 2011; 121: 1780–4.
de Vries JJ1, Vesseur A, Rotteveel LJ, Korver AM, Rusman LG, Wessels E et al. Cytomegalovirus DNA detection in dried blood spots and perilymphatic fluids from pediatric and adult cochlear implant recipients with prelingual deafness. J Clin Virol, 2013; 56(2): 113–7.
Iwasaki S, Usami S. Hearing loss in children with congenital cytomegalovirus infection. In: Manifestations of Cytomegalovirus Infection. Price P, Makana N, Brunt S (eds.), Intech, Croatia, 2013; 1–15.
Edwards LC. Children with cochlear implants and complex needs: a review of outcome research and psychological practice. J Deaf Stud Deaf Educ, 2007; 12(3): 258–68.
Ogawa, H, Suzutani T, Baba Y, Koyano S, Nozawa N, Ishibashi K et al. Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis, 2007; 195(6): 782–8.
Pyman B1, Blamey P, Lacy P, Clark G, Dowell R. The development of speech perception in children using cochlear implants: effects of etiologic factors and delayed milestones. Am J Otol, 2000; 21(1): 57–61.
Lee DJ, Lustig L, Sampson M, Chinnici J, Niparko JK. Effects of cytomegalovirus (CMV) related deafness on pediatric cochlear implant outcomes. Otolaryngol Head Neck Surg, 2005; 133(6): 900–5.
Yoshida H, Kanda Y, Takahashi H, Miyamoto I, Yamamoto T, Kumagami H. Cochlear implantation in children with congenital cytomegalovirus infection. Otol Neurotol, 2009; 30(6): 725–30.
Ramirez JM, Nikolopoulos TP. Cochlear implantation in children deafened by cytomegalovirus: speech perception and speech intelligibility outcomes. Otol Neurotol, 2004; 25(4): 479–82.
Viccaro M, Filipo R, Bosco E, Nicastri M, Mancini P. Long term follow-up of implanted children with cytomegalovirusrelated deafness. Audiol Neurotol, 2012; 17: 395–99.
Matsui T, Ogawa H, Yamada N, Baba Y, Suzuki Y, Nomoto M et al. Outcome of cochlear implantation in children with congenital cytomegalovirus infection or GJB2 mutation. Acta Otolaryngol, 2012; 132(6): 597–602.